Latest Strategy News

Globe Metals & Mining has issued over 56 million shares to Director Bo Tan, settling nearly all of an outstanding loan and achieving a fully debt-free status. This financial milestone positions the company strongly for advancing its Kanyika Niobium Project.

Renascor Resources has completed major equipment installation and begun commissioning at its Australian Government co-funded Purified Spherical Graphite demonstration facility, marking a pivotal step in its sustainable battery anode materials strategy.

Caravel Minerals reports substantial progress on its Definitive Feasibility Study for the Caravel Copper Project, advancing engineering, environmental approvals, and strategic partnerships toward development.

The Supreme Court of New South Wales has approved Southern Cross Media's acquisition of Seven West Media, setting the stage for a significant media industry consolidation early next year.

ADX Energy Ltd is gearing up to resume flow testing at its Welchau-1 well in February 2026 and plans to drill three additional shallow gas wells in Upper Austria, targeting a combined prospective resource of 8.0 BCF.

Scorpion Minerals has executed a binding option agreement to acquire the Old Prospect tenements within its Pharos Gold Project, adding a JORC-compliant resource of over 21,600 ounces of gold. The acquisition consolidates tenure along a highly prospective 5km structural corridor in Western Australia’s Murchison region.

American Tungsten & Antimony Ltd plans to unlock value by spinning out its Drummond Basin and NSW gold exploration assets into a new ASX-listed company, King Metals Limited, aiming to raise up to $6 million in an IPO.

Carnegie Clean Energy’s Spanish subsidiary has sold its 2025 Basque R&D tax deductions for €773,163, securing immediate funding to advance its ocean wave energy technology under the ACHIEVE Programme.

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.

Elevate Uranium Ltd has expanded its global uranium resource to 169 million pounds of U3O8 through the acquisition of the Napperby Uranium Project and complementary assets from Core Lithium Ltd. This move consolidates its Central Australian portfolio and leverages its proprietary U-pgrade™ beneficiation technology.

MRG Metals has raised $0.73 million through a placement to advance its rare earth and heavy mineral sands projects in Mozambique and South Africa, including a strategic acquisition and mining license progression.